Digital Interventions Benefit Patients with Diabetes

Article

Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.

Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.1

The data was recently presented at the 19th Annual Diabetes Technology Meeting conference in Bethesda, Maryland.1

“A blood glucose level of less than 140 mg/dL is an important threshold for a diabetes patient,” said Erez Raphael, chief executive officer of DarioHealth, in a prepared statement. “The [American Diabetes Association] suggests stringent A1c goals of 6.5% (equivalent to 140 mg/dL) for certain diabetic patients, if such levels can be achieved without significant hypoglycemia.”1

According to the American Diabetes Association (AMA), 30.3 million Americans had diabetes in 2015. Of those individuals, approximately 7.2 million were undiagnosed. In 2012, the national cost of diabetes was more than $245 billion, up from $174 billion in 2007. Nutrition, fitness, and monitoring are key to improving health and living with diabetes, according to the AMA.2

The clinical data study relied on DarioHealth Corp.’s digital therapeutics platform, which delivers to users evidence-based interventions that are driven by precision analytics, software, and 1-on-1 coaching.1

Dario’s digital blood glucose monitoring system is accessible through its phone app, and includes modules to monitor medication, weight, blood pressure, food, and exercise. In addition to daily monitoring, the system gives users weekly progress reports, personalized coaching guidance, feedback alerts, and chat features with professionals. A central goal of the system is to combine digital data monitoring with human coaching.1

Among the 162 users, blood glucose levels were reduced by an average of 6% while participating in the 3-month study.1 Furthermore, 51 users considered “high risk”—defined as beginning the study with a blood glucose average above 180 mg/dL—increased their percent in-range measurements by 38% and reduced their blood glucose average by 14% on average.1

The results suggest that personal coaching combined with regular health information such as blood glucose levels, food, and exercise, can significantly assist diabetes patients in managing and improving their chronic condition.

REFERENCES

  • DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes [news release]. New York, NY; Nov 15, 2019. PR Newswire. https://prnmedia.prnewswire.com/news-releases/dariohealth-clinical-study-data-highlights-the-material-benefit-digital-interventions-have-on-glycemic-control-in-users-with-diabetes-300959113.html. Accessed Nov 19, 2019.
  • American Diabetes Association, Statistics. ADA website. https://www.diabetes.org/resources/statistics. Accessed Nov 19, 2019.

Related Videos
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Opill manufacturing | Perrigo
Healthy food selection - Image credit: Alexander Raths | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.